Ex vivo culture of circulating tumor cells using magnetic force-based coculture on a fibroblast feeder layer

Biotechnology Journal

Volumn 11, Issue 11, 2016, Pages 1433-1442

  Yamamoto, Shuhei ^a   Shimizu, Kazunori ^a   Fei, Jiahui ^a   Iwata, Hiroji ^b   Okochi, Mina ^c   Nakanishi, Hayao ^b   Honda, Hiroyuki ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Cancer; Circulating tumor cell; Coculture; Ex vivo culture; Magnetic nanoparticles

Indexed keywords

ADHESION; CELL CULTURE; CYTOLOGY; DISEASES; DRUG THERAPY; FEEDING; FIBROBLASTS; MAGNETISM; MAGNETITE NANOPARTICLES; NANOMAGNETICS; NANOPARTICLES; SELF ASSEMBLY; TUMORS;

CANCER; CIRCULATING TUMOR CELLS; COCULTURE; EX-VIVO; MAGNETIC NANO-PARTICLES;

CELLS;

MAGNETITE NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER THERAPY; CELL ADHESION; CELL PROLIFERATION; CIRCULATING TUMOR CELL; COCULTURE; CONTROLLED STUDY; EX VIVO STUDY; FEEDER CELL; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; MAGNETIC FIELD; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; CELL SEPARATION; CYTOLOGY; FIBROBLAST; MAGNETISM; NEOPLASM; PATHOLOGY; PROCEDURES; TUMOR CELL LINE; TUMOR EMBOLISM;

ANIMALS; CELL LINE, TUMOR; CELL SEPARATION; COCULTURE TECHNIQUES; FEEDER CELLS; FIBROBLASTS; HUMANS; MAGNETICS; MICE; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84996602557     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201600084     Document Type: Article

References (52)

1. Yu, M., Bardia, A., Aceto, N., Bersani, F. et al., Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 2014, 345, 216–220.
2. Nadal, R., Fernandez, A., Sanchez-Rovira, P., Salido, M. et al., Biomarkers characterization of circulating tumour cells in breast cancer patients. Breast Cancer Res. 2012, 14, 12.
3. Sandri, M. T., Zorzino, L., Cassatella, M. C., Bassi, F. et al. Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery. Ann. Surg. Oncol. 2010, 17, 1539–1545.
4. Pantel, K., Brakenhoff, R. H., Dissecting the metastatic cascade. Nat. Rev. Cancer 2004, 4, 448–456.
5. Krebs, M. G., Hou, J. M., Sloane, R., Lancashire, L. et al., Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J. Thorac. Oncol. 2012, 7, 306–315.
6. Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A. et al., Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 2004, 351, 781–791.
7. Lu, C. Y., Tsai, H. L., Uen, Y. H., Hu, H. M. et al., Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer. Br. J. Cancer 2013, 108, 791–797.
8. Thalgott, M., Rack, B., Maurer, T., Souvatzoglou, M. et al., Detection of circulating tumor cells in different stages of prostate cancer. J. Cancer Res. Clin. Oncol. 2013, 139, 755–763.
9. Liu, M. C., Shields, P. G., Warren, R. D., Cohen, P. et al., Circulating tumor cells: A useful predictor of treatment efficacy in metastatic breast cancer. J. Clin. Oncol. 2009, 27, 5153–5159.
10. Lucci, A., Hall, C. S., Lodhi, A. K., Bhattacharyya, A. et al., Circulating tumour cells in non-metastatic breast cancer: A prospective study. Lancet Oncol. 2012, 13, 688–695.
11. Went, P. T., Lugli, A., Meier, S., Bundi, M. et al., Frequent EpCam protein expression in human carcinomas. Hum. Pathol. 2004, 35, 122–128.
12. Sieuwerts, A. M., Kraan, J., Bolt, J., van der Spoel, P. et al., Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J. Natl. Cancer Inst. 2009, 101, 61–66.
13. Vona, G., Estepa, L., Béroud, C., Damotte, D. et al., Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 2004, 39, 792–797.
14. Yu, M., Bardia, A., Wittner, B., Stott, S. L. et al., Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013, 339, 580–584.
15. Hosokawa, M., Hayata, T., Fukuda, Y., Arakaki, A. et al., Size-selective microcavity array for rapid and efficient detection of circulating tumor cells. Anal. Chem. 2010, 82, 6629–6635.
16. Vona, G., Sabile, A., Louha, M., Sitruk, V. et al., Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am. J. Pathol. 2000, 156, 57–63.
17. Desitter, I., Guerrouahen, B. S., Benali-Furet, N., Wechsler, J. et al., A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res. 2011, 31, 427–441.
18. Yusa, A., Toneri, M., Masuda, T., Ito, S. et al., Development of a new rapid isolation device for circulating tumor cells (CTCs) using 3D Palladium filter and its application for genetic analysis. PLoS One 2014, 9, e88821.
19. Ozkumur, E., Shah, A. M., Ciciliano, J. C., Emmink, B. L. et al., Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci. Transl. Med. 2013, 5, 11.
20. Ameri, K., Luong, R., Zhang, H., Powell, A. A. et al., Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Br. J. Cancer 2010, 102, 561–569.
21. Yamamoto, S., Fei, J., Okochi, M., Shimizu, K. et al., Efficient capturing of circulating tumor cells using a magnetic capture column and a size-selective filter. Bioprocess Biosyst. Eng. 2015, 38, 1693–1704.
22. Ino, K., Okochi, M., Honda H. Application of magnetic force-based cell patterning for controlling cell-cell Interactions in angiogenesis. Biotechnol. Bioeng. 2009, 102, 882–890.
23. Okochi, M., Takano, S., Isaji, Y., Senga, T. et al., Three-dimensional cell culture array using magnetic force-based cell patterning for analysis of invasive capacity of BALB/3T3/v-src. Lab Chip 2009, 9, 3378–3384.
24. Yamamoto, S., Hotta, M. M., Okochi, M., Honda, H., Effect of vascular formed endothelial cell network on the invasive capacity of melanoma using the in vitro 3D co-culture patterning model. PLoS One 2014, 9, e103502.
25. Shimizu, K., Ito, A., Yoshida, T., Yamada, Y. et al., Bone tissue engineering with human mesenchymal stem cell sheets constructed using magnetite nanoparticles and magnetic force. J. Biomed. Mater. Res. Part B 2007, 82, 471–480.
26. Okochi, M., Matsumura, T., Yamamoto, S., Nakayama, E. et al., Cell behavior observation and gene expression analysis of melanoma associated with stromal fibroblasts in a three-dimensional magnetic cell culture array. Biotechnol. Progr. 2013, 29, 135–142.
27. Yamamoto, S., Okochi, M., Jimbow, K., Honda, H., Three-dimensional magnetic cell array for evaluation of anti-proliferative effects of chemo-thermo treatment on cancer spheroids. Biotechnol. Bioprocess Eng. 2015, 20, 488–497.
28. Takahashi, K., Narita, M., Yokura, M., Ichisaka, T. et al., Human induced pluripotent stem cells on autologous feeders. PLoS One 2009, 4, e8067.
29. Zhou, Y., Mao, H. L., Joddar, B., Umeki, N. et al., The significance of membrane fluidity of feeder cell-derived substrates for maintenance of iPS cell stemness. Sci. Rep. 2015, 5, 13.
30. Olaso, E., Santisteban, A., Bidaurrazaga, J., Gressner, A. M. et al., Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 1997, 26, 634–642.
31. Kalluri, R., Zeisberg, M., Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6, 392–401.
32. Erez, N., Truitt, M., Olson, P., Arron, S. T., Hanahan, D., Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappa B-dependent manner. Cancer Cell 2010, 17, 135–147.
33. Martinez-Outschoorn, U. E., Trimmer, C., Lin, Z., Whitaker-Menezes, D. et al., Autophagy in cancer associated fibroblasts promotes tumor cell survival Role of hypoxia, HIF1 induction and NF kappa B activation in the tumor stromal microenvironment. Cell Cycle 2010, 9, 3515–3533.
34. Ito, Y., Nakanishi, H., Kodera, Y., Hirai, T. et al., Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV. Cancer Sci. 2010, 101, 1853–1860.
35. United Kingdom Co-Ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia, 2nd Edn. Br. J. Cancer 1998, 77, 1–10.
36. O'Reilly, N., Gallagher, C., Reddy Katikireddy, K., Clynes, M. et al., Demodex-associated bacillus proteins induce an aberrant wound healing response in a corneal epithelial cell line: Possible implications for corneal ulcer formation in ocular rosacea. Invest. Ophthalmol. Visual Sci. 2012, 53, 3250–3259.
37. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., Ellis, L. M., Expression of vascular endothelial growth-factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon-cancer. Cancer Res. 1995, 55, 3964–3968.
38. Kurschat, P., Wickenhauser, C., Groth, W., Krieg, T., Mauch, C., Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography. J. Pathol. 2002, 197, 179–187.
39. Nakajima, S., Doi, R., Toyoda, E., Tsuji, S. et al., N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin. Cancer Res. 2004, 10, 4125–4133.
40. Viale, M., Cordazzo, C., Cosimelli, B., de Totero, D. et al., Inhibition of MDR1 activity in vitro by a novel class of diltiazem analogues: Toward new candidates. J. Med. Chem. 2009, 52, 259–266.
41. Lu, X., Yan, C. H., Yuan, M., Wei, Y. et al., In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer. Cancer Res. 2010, 70, 3905–3914.
42. Fernandez, S. V., Bingham, C., Fittipaldi, P., Austin, L. et al., TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients. Breast Cancer Res. 2014, 16, 445.
43. Lyberopoulou, A., Aravantinos, G., Efstathopoulos, E. P., Nikiteas, N. et al., Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue. PLoS One 2015, 10, e0123902.
44. Wang, Y. H., Dong, Y. Y., Wang, W. M., Xie, X. Y. et al., Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-kappa B pathways induced by paracrine cytokines. J. Exp. Clin. Cancer Res. 2013, 32, 51.
45. Chen, G. Q., Goeddel, D. V., TNF-R1 signaling: A beautiful pathway. Science 2002, 296, 1634–1635.
46. Oeckinghaus, A., Hayden, M. S., Ghosh, S., Crosstalk in NF-kappa B signaling pathways. Nat. Immunol. 2011, 12, 695–708.
47. Beyaert, R., Cuenda, A., VandenBerghe, W., Plaisance, S. et al., The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor. EMBO J 1996, 15, 1914–1923.
48. Wang, W., Nag, S. A., Zhang, R., Targeting the NFκB signaling pathways for breast cancer prevention and therapy. Curr. Med. Chem. 2015, 22, 264–289.
49. Ito, A., Ino, K., Hayashida, M., Kobayashi, T. et al., Novel methodology for fabrication of tissue-engineered tubular constructs using magnetite nanoparticles and magnetic force. Tissue Eng. 2005, 11, 1553–1561.
50. Shimizu, K., Ito, A., Lee, J. K., Yoshida, T. et al., Construction of multi-layered cardiomyocyte sheets using magnetite nanoparticles and magnetic force. Biotechnol. Bioeng. 2007, 96, 803–809.
51. Shimizu, K., Ito, A., Honda, H., Mag-seeding of rat bone marrow stromal cells into porous hydroxyapatite scaffolds for bone tissue engineering. J. Biosci. Bioeng. 2007, 104, 171–177.
52. Horie, M., Ito, A., Maki, T., Kawabe, Y. et al., Magnetic separation of cells from developing embryoid bodies using magnetite cationic liposomes. J. Biosci. Bioeng. 2011, 112, 184–187.